Abstract.
Dysfunction of the mitochondrial respiratory chain has been recognised as a cause of human disease for over 30 years. Advances in the past 10 years have led to a better understanding of the genetics and molecular pathogenesis of many of these disorders. Over 100 primary defects in mitochondrial DNA (mtDNA) are now implicated in the pathogenesis of a group of disorders which are collectively known as the mitochondrial encephalomyopathies, and which most frequently involve skeletal muscle and/or the central nervous system. Although impaired oxidative phosphorylation is likely to be the final common pathway leading to the cellular dysfunction associated with such mtDNA mutations, the complex relationship between genotype and phenotype remains largely unexplained. Most of the genes which encode the respiratory chain reside in the nucleus, yet only five nuclear genes have been implicated in human respiratory chain diseases. There is evidence that respiratory chain dysfunction is present in common neurological diseases such as Parkinson’s disease and Huntington’s disease. The precise cause of this respiratory chain dysfunction and its relationship to the disease process are unclear. This review focuses upon respiratory chain disorders associated with primary defects in mtDNA.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 13 July 1998; received after revision 26 November 1998; accepted 26 November 1998
Rights and permissions
About this article
Cite this article
Hanna, M., Nelson, I. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. CMLS, Cell. Mol. Life Sci. 55, 691–706 (1999). https://doi.org/10.1007/s000180050327
Published:
Issue Date:
DOI: https://doi.org/10.1007/s000180050327